Baji, Petra; Péntek, Márta; Czirják, László; … - In: The European Journal of Health Economics 15 (2014) 1, pp. 53-64
This is the first indirect meta-analysis in RA that compares the efficacy and safety of biosimilar-infliximab to the other biologicals indicated in RA. We found no significant difference between infliximab-biosimilar and other biological agents in terms of clinical efficacy and safety. </AbstractSection>...